Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
<p>Abstract</p> <p>Background</p> <p>Endoglin (CD105) has been considered a prognostic marker for hepatocellular carcinoma (HCC), and widely used as an appropriate targeting for antiangenesis therapy in some cancers. Our aim was to evaluate the distribution and expressi...
Main Authors: | Chen Jun, Sun Xitai, Zhuang Linyuan, Yu Decai, Yao Yongzhong, Meng Kui, Ding Yitao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/7/122 |
Similar Items
-
Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy
by: Aldona Kasprzak, et al.
Published: (2018-12-01) -
Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma
by: Virginia Di Paolo, et al.
Published: (2018-01-01) -
Endoglin Expression (CD105) in Ephithelial Ovarian Cancer
by: Rizkinov Jumsa, et al.
Published: (2018-04-01) -
Expression of Endoglin (CD-105) and Microvessel Density in Oral Dysplasia and Squamous Cell Carcinoma
by: Maharudrappa Basnaker, et al.
Published: (2014-09-01) -
The Role of Endoglin in Hepatocellular Carcinoma
by: Kuo-Shyang Jeng, et al.
Published: (2021-03-01)